Evidence map›Paper›PMID 29909548›Full record

ArticleActa neuropathologica2018

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

Kristian W Pajtler, Ji Wen, Martin Sill, Tong Lin, Wilda Orisme, Bo Tang, Jens-Martin Hübner, Vijay Ramaswamy, Sujuan Jia, James D Dalton and 33 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Acta neuropathologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05151718 (Ependymomics), which is not on this map. Cited by 169 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 2 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05151718 recruitingnot on this mapstarted 2021, after this paper: background citation

Ependymomics: Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

TypeobservationalSponsorInstitut Claudius RegaudRan2021 to 2026Enrolled370ConditionsEpendymoma of Brain, Pediatric Solid Tumor
3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 2 syntheses or guidelines pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Article
  12. A brief history of ependymoma.Neuro-oncology · 2026
    Review
  13. Brain tumor research and treatment · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 8 institutions in 4 countries.

Kristian W PajtlerHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Ji WenDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Martin SillHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Tong LinDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Wilda OrismeDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Bo TangDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Jens-Martin HübnerHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Vijay RamaswamyDivision of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, M5G 1X8, Canada.
Sujuan JiaDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
James D DaltonDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Kelly HaupfearDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Hazel A RogersChildren's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK.
Chandanamali PunchihewaDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Ryan LeeDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
John EastonDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Gang WuDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Timothy A RitzmannChildren's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK.
Rebecca ChapmanChildren's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK.
Lukas ChavezHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Fredrick A BoopDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Paul KlimoDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Noah D SabinDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Robert OggDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Stephen C MackDivision of Neurosurgery, Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, M5G 1X8, Canada.
Brian D FreibaumDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Hong Joo KimDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Hendrik WittHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
David T W JonesHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Baohan VoDepartment of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Amar GajjarDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Stan PoundsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Arzu Onar-ThomasDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Martine F RousselDepartment of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Jinghui ZhangDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
J Paul TaylorDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Thomas E MerchantDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Richard GrundyChildren's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK.
Ruth G TatevossianDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Michael D TaylorDivision of Neurosurgery, Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, M5G 1X8, Canada.
Stefan M PfisterHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
Andrey KorshunovDepartment of Neuropathology, University of Heidelberg, Heidelberg, Germany.
Marcel KoolHopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), 69120, Heidelberg, Germany.
David W EllisonDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA. David.Ellison@stjude.org.
St. Jude Children's Research Hospital · USNational Center for Tumor Diseases · DEHeidelberg University · DEBrain Tumour Research · GBUniversity of Nottingham · GBBaylor College of Medicine · USHospital for Sick Children · CASickKids Foundation · CA

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0M
Deutsche Krebshilfe 109252KIKA 90NCI NIH HHS P01 CA096832NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

Of nine ependymoma molecular groups detected by DNA methylation profiling, the posterior fossa type A (PFA) is most prevalent. We used DNA methylation profiling to look for further molecular heterogeneity among 675 PFA ependymomas. Two major subgroups, PFA-1 and PFA-2, and nine minor subtypes were discovered. Transcriptome profiling suggested a distinct histogenesis for PFA-1 and PFA-2, but their clinical parameters were similar. In contrast, PFA subtypes differed with respect to age at diagnosis, gender ratio, outcome, and frequencies of genetic alterations. One subtype, PFA-1c, was enriched for 1q gain and had a relatively poor outcome, while patients with PFA-2c ependymomas showed an overall survival at 5 years of > 90%. Unlike other ependymomas, PFA-2c tumors express high levels of OTX2, a potential biomarker for this ependymoma subtype with a good prognosis. We also discovered recurrent mutations among PFA ependymomas. H3 K27M mutations were present in 4.2%, occurring only in PFA-1 tumors, and missense mutations in an uncharacterized gene, CXorf67, were found in 9.4% of PFA ependymomas, but not in other groups. We detected high levels of wildtype or mutant CXorf67 expression in all PFA subtypes except PFA-1f, which is enriched for H3 K27M mutations. PFA ependymomas are characterized by lack of H3 K27 trimethylation (H3 K27-me3), and we tested the hypothesis that CXorf67 binds to PRC2 and can modulate levels of H3 K27-me3. Immunoprecipitation/mass spectrometry detected EZH2, SUZ12, and EED, core components of the PRC2 complex, bound to CXorf67 in the Daoy cell line, which shows high levels of CXorf67 and no expression of H3 K27-me3. Enforced reduction of CXorf67 in Daoy cells restored H3 K27-me3 levels, while enforced expression of CXorf67 in HEK293T and neural stem cells reduced H3 K27-me3 levels. Our data suggest that heterogeneity among PFA ependymomas could have clinicopathologic utility and that CXorf67 may have a functional role in these tumors.

Indexed as

DNA MethylationEpendymomaFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHEK293 CellsHistonesHumansInfratentorial NeoplasmsMaleMutationOncogene ProteinsTransfectionEZHIP protein, humanHistonesOncogene ProteinsCXorf67DNA methylation profilingEpendymomaH3 K27MH3 K27-trimethylationMolecular heterogeneityPRC2

Identifiers

PMID29909548
PMCPMC6105278
OpenAlexW2807973758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.